NewAmsterdam Pharma NAMS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 35.08 | -0.62 | -65,980 | -75 | ||
| 2025Q3 | 28.44 | -0.61 | -55,143 | -72 | ||
| 2025Q2 | 18.11 | -0.15 | -35,635 | -17 | ||
| 2025Q1 | 20.47 | -0.34 | -68,925 | -40 | ||
| 2024Q4 | 25.70 | -0.91 | -46,434 | -92 | ||
| 2024Q3 | 16.60 | -0.18 | -25,003 | -17 | ||
| 2024Q2 | 19.21 | -0.41 | -52,575 | -39 | ||
| 2024Q1 | 23.65 | -1.06 | -55,482 | -94 | ||
| 2023Q4 | 11.17 | -49,195 | -49 | |||
| 2023Q3 | 9.25 | -0.57 | -48,283 | -47 | ||
| 2023Q2 | 11.89 | -0.47 | -38,999 | -38 | ||
| 2023Q1 | 13.26 | -0.51 | -38,628 | -42 | ||
| 2022Q4 | 10.90 | |||||
| 2022Q3 | 47.98 | -0.54 | -2,294 | -5 | ||
| 2022Q2 | 169.74 | -0.14 | -1,991 | -1 | ||
| 2022Q1 | -24.93 | 0.16 | -345 | 1 | ||
| 2021Q4 | -48.98 | -0.12 | -455 | 1 |